Vepoloxamer

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameVepoloxamer
Drug Alias NameFLOCORPoloxamer-188-NFCRL-5861Purified-188ANX-188 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane structures modulators
TargetsNot applicable
Therapy Area/IndicationsIschemiaAnemia, Sickle CellHeart Failure +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumPanamaUnited States +[12] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCytrx Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytrx CorpMast Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsIschemiaAnemia, Sickle CellHeart Failure +[4] 

Other Information

ATC CodeN/A
Related LinksN/A